Market Tracker

02/27 6:02pm ET

Alkermes Plc (NASDAQ:ALKS)

70.25
Delayed Data
As of Feb 27
 -0.98 / -1.38%
Today’s Change
38.49
Today|||52-Week Range
74.96
+19.96%
Year-to-Date

Today’s Trading

Previous close71.23
Today’s open71.68
Day’s range69.81 - 72.10
Volume6,215,947
Average volume (3 months)1,320,871
Market cap$10.4B
Dividend yield--
Data as of 4:00pm ET, 02/27/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-79.58%
Earnings growth (next 5 years)+69.48%
Revenue growth (last year)+47.59%
P/E ratio585.4
Price/Sales5.42
Price/Book9.87

Competitors

 Today’s
change
Today’s
% change
JAZZJazz Pharmaceuticals...-5.10-2.91%
SLXPSalix Pharmaceutical...+0.25+0.16%
MDVNMedivation Inc-2.21-1.85%
RDYDr.Reddy's Laborator...-0.02-0.04%
Data as of 4:14pm ET, 02/27/2015

Financials

Next reporting dateApril 29, 2015
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$575.5M
Annual profit (last year)$25.0M
Net profit margin4.34%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Richard F. Pops
President
Shane M. Cooke
Corporate headquarters
Dublin, Dublin

Forecasts